DAPA-CKD: Dapagliflozin in Patients With Chronic Kidney Disease

Prof David Wheeler
Professor, Kidney Medicine at University College London, UK Honorary Consultant Nephrologist at the Royal Free London NHS Foundation Trust

Listen to Prof. David Wheeler’s Discussion on the FAQ about the DAPA-CKD Trial

Back to top